Werner Seiz

Rationale and Design of ATHENA: <b>A</b> Placebo‐Controlled, Double‐Blind, Parallel Arm <b>T</b>rial to Assess the Efficacy of Dronedarone 400 mg Bid for the Prevention of Cardiovascular <b>H</b>ospitalization or Death from Any Cause in Pati<b>EN</b>ts with <b>A</b>trial Fibrillation/Atrial Flutter

Stefan H. Hohnloser, Stuart J. Connolly, Harry J.G.M. Crijns et al. · Journal of Cardiovascular Electrophysiology · 2007 · 82 citations

Medicine, Cardiology, Pharmacology +14

Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia

Joep C. Defesche, Claudia Stefanutti, Gisle Langslet et al. · Journal of clinical lipidology · 2017 · 55 citations · Full text

Life Sciences, Genetics, Pharmacology +11

Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia

Merel L. Hartgers, Joep C. Defesche, Gisle Langslet et al. · Journal of clinical lipidology · 2017 · 52 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

HMR 1098: An Inhibitor of Cardiac ATP‐Sensitive Potassium Channels

Heinz Gögelein, Heinrich Englert, Astrid Kotzan et al. · Cardiovascular Drug Reviews · 2000 · 14 citations

Medicine, Pharmacology, Physiology +14

Understanding the Specific Implications of Amino Acids in the Antibody Development

Akshata S. Gavade, Anil Kumar Nagraj, Riya Patel et al. · The Protein Journal · 2024 · 10 citations

Pharmacy, Biochemistry, Immunology +16